Light treatment for type 2 diabetes
Part of Hormones & metabolism clinical trials.
This study tests a non-invasive treatment called biophoton therapy (using light energy) to see if it can help control blood sugar in people with type 2 diabetes. If you qualify, you would receive this therapy and the research team would monitor your progress.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult between 18 and 70 years old
- You have been diagnosed with type 2 diabetes
- You are generally healthy besides the diabetes (no other major illnesses)
- You are able to speak and understand English well enough to follow the study
- You are not currently in another experimental drug or device trial
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is a screening study to identify and understand people with type 2 diabetes whose blood sugar isn't well controlled, so they can potentially join future diabetes research trials. You won't receive a new treatment in this study—it's about getting to know your health history and seeing if you might be a good fit for upcoming studies.
This trial tests whether shining a special light on the body (called photobiomodulation) can help improve blood sugar control in people with type 2 diabetes. It may be a gentle addition to your current diabetes care.
This study tests a painless light treatment (photobiomodulation) to see if it can prevent foot ulcers in people with type 2 diabetes who are at risk. If you qualify, you would receive the treatment regularly and be monitored for foot health.
This study tests whether light therapy can improve how cells make energy and reduce stress on the body, in both healthy people and people with type 1 diabetes. If you join, you may learn if this approach helps your body function better.
This trial tests a new procedure called pulse electric field ablation to see if it can help people with type 2 diabetes whose blood sugar is not well controlled by oral medications. The procedure uses a small device passed through the mouth to the upper intestine.
This study tests an experimental medicine called RGB-5088 for people with type 2 diabetes who are already using insulin. The goal is to see if it can safely improve blood sugar control when added to your current diabetes management.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.